Robert Flavell

Selective Treatment of Acute Myeloid Leukemia with Radioimmunotherapies Targeting the Active Conformation of Integrin Beta-2

National Cancer Institute · R01

PI · $1.4M · University of California, San Francisco

Systematic Evaluation of Toxicity and Therapeutic Efficacy in CD46 Directed Radioligand Therapy

National Cancer Institute · R01

Contact PI · $2.6M · University of California, San Francisco

Molecular Imaging of Novel PARP Inhibitor Nanomedicine Delivery

National Cancer Institute · R01

PI · $2.4M · University of California, San Francisco

Development of CD46 Theranostics for Imaging and Treatment of Multiple Myeloma

National Cancer Institute · R01

Contact PI · $3.3M · University of California, San Francisco

Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

Principal investigator · Not yet recruiting · Phase 1

Robert Flavell, MD, PhD

PET [89Zr]DFO-starPEG in Solid Tumors

Principal investigator · Recruiting · Phase 1

Robert Flavell, MD, PhD

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

Principal investigator · Active not recruiting · Early phase 1

Robert Flavell, MD, PhD

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Principal investigator · Recruiting · Phase 1

Robert Flavell, MD, PhD